|
Industry Trends
An Analysis of Worldwide
Prescription and OTC Sales by
Technology
(2002 - 2012)
By Mark P. Mathieu
EvaluatePharma®
calculates that worldwide
pharmaceutical sales from
biotechnology products increased
20%, to $94bn, in 2007.
Read more
|
|
Latest eNewsletters
eCliniqua
New Privacy Concerns with
'HIPAA 2'
Jan 4, 2010
Pharma
Services
News
BioSeek-Asterand Deal is Rich
with Synergy
Dec 9, 2009
|
|
Sales Contacts
For advertising
information contact:
Alan El
Faye
VP, Advertising Sales - Western
US, Canada, Europe, Pacific Rim
213-300-3886
Kay O.
Christopher
Regional Sales Manager,
Advertising Sales -
Eastern US, Midwest and India
860-693-2991
|
|
|
|
Link to Us!
You are welcome to link to
articles on our website. Contact
Allison Proffitt
for details.
e-Prints &
Reprints
To post a full article
from
Weekly Update
or
Bio-IT World
on your website (not just a link),
or for paper reprints, please
contact:
Ashley
Zander
The YGS Group
717-505-9701 ext.125
|
|
|
|
|
|
IN THIS ISSUE
|
|
SNPedia's Top Ten
SNPs of the Year
|
|
|
Checking In on the
Century of Biology
|
|
|
AstraZeneca Saves
$150m with Better Data
Management
|
|
|
23andMe Gains $27.8
Million in Funding
|
|
Tools
now
available
for
drug
and
molecular
discovery
from
sequence
through
lead
optimization
Computational
chemists
and
molecular
modelers
can
now
produce
and
optimize
lead
candidates,save
time
in
processes,smooth
and
simplify
workflows,
and
accelerate
the
pace
of
discovery.
With
newly
available
tools.
If
you
can
think
of
an
experiment,
you
do
can
do
it
Click
to
learn
more
.
|
|
|
| |
|
THIS WEEK IN BIO-IT
|
| |
|
SNPedia's Top
Ten SNPs of the Year
The creators of the
excellent SNPedia, Greg
Lennon and Michael Cariaso,
have selected their favorite
ten SNPs from the wiki that
totals nearly 10,000
polymorphisms, based on their
selective evaluation of
medical importance,
statistical rigor, and
general interest.
SNPedia
Checking In on the
Century of Biology
The 21st century
was destined to be the
century of biology, but
bioscience has not delivered
results as quickly as some
had hoped.
Financial Times
AstraZeneca Saves
$150m with Better Data
Management
AstraZeneca is
reportedly on track to save
$150m in reduced IT costs and
increased efficiency thanks
to better data management for
clinical trials.
Computing
23andMe Gains $27.8
Million in Funding
After Linda
Avey's departure in
September and layoffs in
October, 23andMe has
completed a $27.8 million
second round of funding.
Silicon Valley Business
Journal
Novartis Unveils
new Corporate Campus in
Basel
Daniel Vasella, the
chief executive of the
Novartis, discusses the
architectural vision behind
the Swiss pharma's
resplendent new campus in
Basel.
New York Times
Pharma's Love
Affairs
If 2007 was the
year pharma fell in love with
biologics, then 2009 was the
year it finally learned to
love itself.
The Motley Fool
Aveo
Pharmaceuticals Files for
IPO
Aveo
Pharmaceuticals, a former
Bio-IT World
"company to watch,"
signaled a brighter 2010 for
the pharma industry by filing
for an Initial Public
Offering.
Bio-IT World
Leprosy
Susceptibility Genes
Identified
Scientists at the
Genome Institute of Singapore
(GIS) have completed the
first-ever genome-wide
association study of leprosy
and the largest GWAS effort
on infectious disease. In
collaboration with 26
institutes in China, GIS
identified seven genes that
cause people to be
susceptible to leprosy. The
results were published
yesterday in the New England
Journal of Medicine.
Bio-IT World
Cancer Genomes
Suggest One Mutation for
Every 15 Cigarettes
Scientists from the
Wellcome Trust Sanger
Institute and Life
Technologies have
reconstructed the biological
history of two types of
cancer in a genetic tour de
force that promises to
transform medical treatment
of the disease.
The Times
George Church's
Challenge to the Genomics
Generation
George Church talks
about the history of personal
genomics, the benefits of
genome mapping, and the
responsibiliteis of the first
genomic generation.
Newsweek
|
|
| |
|
|
|
|
Increase
Research
IT
Productivity
With
Improved
Scientific
Data
Management
Today's
R&D
teams
look
to
IT
to
help
meet
demanding
innovation
schedules.
Learn
how
Pipeline
Pilot,
Accelrys'
Scientific
Informatics
Platform,
is
easily
deployed
by
IT,
enabling
R&D
to
quickly
access,
analyze
and
report
on
data,
regardless
of
where
it
resides
or
what
format
it
is
in.
Download
the
whitepaper.
|
|
|
| |
|
|
|
| |
|
PODCASTS
How
New Molecular
Modeling Software is
Dramatically
Improving
Workflows
Sponsored by Tripos
Advanced molecular
modeling software now has
the ability to make
routine tasks faster and
easier for life
scientists, and
researchers. Significant
benefits include the
enhancement of key
discovery workflows from
obtaining data to
delivering
findings. In this
brief podcast, learn
about:
-
New avenues for science
being opened up through
exciting; new software
advancements
-
Strategy and
applications driving
computer-aided design
that are increasing
scientific productivity
and efficiency
Download
now
Technology
Challenges and Outlook
for Drug Safety
Management in Clinical
Trials
Sponsored by
Medidata
This podcast will discuss
the drug safety
regulation challenges
that the
biopharmaceutical
industry is facing in
clinical trials and the
emerging new technologies
that can help researchers
to address them.
Industry experts and
executives from Medidata
will address the
following
questions:
-
What are the challenges
associated with drug safety
in clinical trials?
-
How can a clinical study
sponsor be better prepared
for regulatory agency
safety inspections?
-
What is the
outlook
of technology in safety
data management?
Download now
To have
your podcast
featured here,
contact
Lynn
Cloonan
for more
information.
|
|
| |
|
SPONSORED
LINKS
To have
your product or service
featured here,
contact
Lynn
Cloonan
for
more information.
|
|
| |
|
Insight
Pharma Reports
Immunotherapies
and Vaccines for
Nontraditional
Indications
Author: Lucy J.
Sannes, PhD, MBA
Applications of
immunotherapies and
vaccines for prevention and
treatment of infectious
diseases and cancer are
well known.
Immunotherapies being
developed or used for
treatment of other diseases
(i.e., beyond prevention
and treatment of infectious
diseases and cancer) are
the focus of this report.
These may work by different
mechanisms of action, and
available information
regarding how these
immunotherapies work is
presented.
Read more
.
|
|
| |
|
FEATURED
EVENTS
-
Molecular Med
Tri-Conference Short
Courses
-
Adopting R&D
Informatics
Systems
-
Tufts Postgraduate Course
in Clinical Pharmacology,
Drug Development and
Regulation | Feb 8-12,
2010 | Boston
-
Electronic Data in
Clinical Trials, March
8-9, 2010,
Philadelphia
-
eCTD 2010 - One Day
Forum, March 10, 2010,
Philadelphia
-
Summit for Clinical Ops
Executives (SCOPE) -
March 8-11, 2010 |
Philadelphia
-
Drug Development Latin
America, March 10-11,
2010, Philadelphia
-
Bio-IT World Conference
& Expo • April 20-22,
2010, World Trade Center
•Boston, MA
-
Bio-IT World Web Symposia
Series
-
Barnett Educational
Services
-
Cambridge Healthtech
Events
To have your event featured
here, contact
Lynn
Cloonan
for more information.
|
|
|
|
|
|
|
BEST PRACTICES 2010
|
|
Bio-IT
World's 2010
Best Practices Awards
Program
Entry forms
are now available for
Bio-IT World's 2010 Best
Practices Awards program.
The program is
intended to spotlight
companies whose use of
innovative technologies
is making a positive
difference in biomedical
R&D and drug
discovery and
development.
Bio-IT
World is also making
available a free compendium of
Best Practice entries from 2009
to help ensure the lessons
learned are widely spread. The
compendium can be downloaded
here
.
Full
details of the entry process and
the entry form are available by
clicking
here
.
The deadline is
January 18, 2010.
2009 Best Practice
Categories:
*Basic Research & Biological
Research
*Drug Discovery & Development
*Clinical Trials & Research
*Translational Medicine
*Personalized Medicine
*IT & Informatics
*Knowledge Management
*Health-IT
*Manufacturing &
Bioprocessing
If you have
questions, write to
aproffitt@healthtech.com
|
|
|
|
FEATURED CONTENT
|
|
The Promise of
Imaging Biomarkers
Imaging biomarkers
are poised to join biochemical
and molecular markers as
drivers of drug development and
disease management. They enable
researchers and clinicians to
see into the body without
invasive procedures. They
frequently provide earlier
detection of disease and its
progression than molecular
markers. Researchers use them
to see in detail how their
candidate drugs behave such as
determining the percentage of
target receptors occupied by a
drug or observing a drug's
ability to cross the
blood/brain barrier. They
promise to save time and money
too.
Download this white
paper
. (Sponsored by:
Thomson Reuters )
Beyond EDC…Optimizing
ROI by
Streamlining Clinical
Research Processes
Although EDC brings tremendous
efficiencies to clinical data
collection, numerous repetitive
clinical development activities
exist beyond its scope which are
in need of more efficient
processes. As these
activities move from paper-based
to electronic, the transition can
be eased through the use of
intelligent PDF forms.
Using XML capabilities,
intelligent forms can follow
workflows while leveraging
established point solutions such
as EDC, CTMS and IV/IWRS to
optimize return on
investment.
Download
Whitepaper
(Sponsored by:
Adobe)
Protect Your Scientific
Intellectual
Property: Proof of Lab
Informatics Data Authenticity is
Your Best Legal Defense
As a bio-technology or
life sciences organization, your
formulas, treatments and research
and discoveries are the "lifeblood"
of your business. But if you
aren't protecting the integrity
of your scientific data in your lab
informatics systems, you risk
losing IP ownership, revenue and
consequently your business if you
can't prove time-of-creation
and data authenticity. Learn how
you can implement simple,
cost-effective and automated
controls to protect your scientific
intellectual property.
Download
Whitepaper
(Sponsored by: Surety,
LLC)
The Key to Life Sciences
Data
Management: Transparent
Migration
Life sciences organizations face
new data management challenges as
the volume of research data grows
and more data is kept online for
longer times.
Download
Whitepaper
(Sponsored by:
BlueArc)
To have your white paper
featured here, contact
Lynn
Cloonan
for more
information.
|
|
|
|
EXCLUSIVE WEBCAST
|
|
Life Science Webcasts from
Bio-IT World and Cambridge
Healthtech Media Group
New
Moore's Law and
the Future of
Genome
Sequencing
Guest:
Jonathan
Rothberg,
Ph.D.,
Founder/CEO Ion
Torrent
Systems;
Founder
Curagen, 454
Life Sciences,
Rain Dance
Editorial
inteview
conducted by
Kevin Davies,
Ph.D.,
Editor-in-Chief
of
Bio-IT
World
with Jonathan
Rothberg
reflecting on
the past decade
of his
accomplishments
and a glimpse
at his new
project, Ion
Torrent
Systems.
Interview
conducted at
CHI's Exploring
Next Generation
Sequencing
conference in
September
2009.
Download
Now
New
Oxford Nanopore's
Third-Generation Sequencing
Technology
Guest:
John Milton, Ph.D., Vice
President Research, Oxford
Nanopore Technologies UK
Editorial interview conducted by
Kevin Davies, Ph.D.,
Editor-in-Chief of
Bio-IT World
with John Milton that offers
insights into Oxford Nanopore's
potentially revolutionary new
sequencing technology, which
marries exonuclease cleavage of
DNA and protein nanopores.
Interview conducted at CHI's
Exploring Next Generation
Sequencing conference in
September 2009.
Download Now
|
|
|
|
Contact the Editor
|
We invite your
comments and feedback for this
edition of
Weekly Update
.
Managing Editor
|
|
Follow
